NEW YORK (GenomeWeb News) – WaferGen Biosystems said today that its SmartChip Real-Time PCR System will be used in preclinical and clinical studies of ImmuneRegen's wound-healing drug candidate Homspera.

The studies will be carried out by researchers at the University of Texas Southwestern Medical Center. They will use the SmartChip system to validate relevant gene expression biomarkers and to assess their impact on patient response to treatment.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.